z-logo
open-access-imgOpen Access
Complete remission of an oropharyngeal cancer to nivolumab even after immunotherapy discontinuation
Author(s) -
Manuel Stöth,
Thomas J. Meyer,
Matthias Scheich,
Stephan Hackenberg,
Agmal Scherzad
Publication year - 2020
Publication title -
laryngo-rhino-otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0040-1711037
Subject(s) - nivolumab , discontinuation , medicine , immunotherapy , oncology , complete remission , complete response , cancer , head and neck , quality of life (healthcare) , head and neck squamous cell carcinoma , basal cell , head and neck cancer , surgery , chemotherapy , nursing

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom